Takeda

takedasd.com

Takeda San Diego, Inc.

10410 Science Center Drive
92121 San Diego
USA

Phone

takedasd.com
Contact
Profile News

About Takeda

Takeda San Diego (TSD) is Takeda's global center for excellence in structure-based drug discovery. TSD integrates cutting-edge protein crystallography and drug discovery technologies to efficiently generate Investigational New Drug (IND) candidates for the treatment of metabolic diseases and cancer.

Read more about Takeda

Advertisement

Revolutionize your production: real-time Raman analysis for maximum efficiency
Revolutionize your production: real-time Raman analysis for maximum efficiency
Efficient inline analysis for liquids and solids
Efficient inline analysis for liquids and solids
User-friendly software for effortless Design of Experiments (DoE)
User-friendly software for effortless Design of Experiments (DoE)

News about Takeda

Takeda

28-Jul-2025 | business & finance

Takeda strengthens Berlin site as future German headquarters

The Constance site will be closed by the end of 2028

Read news
Takeda

01-Dec-2016 | business & finance

Takeda to invest more than 100 million Euros in dengue vaccine manufacturing plant

Takeda Pharmaceutical Company Limited announced that it will invest more than 100 Million Euros to build a new manufacturing plant for its dengue vaccine ...

Read news
Takeda

15-Oct-2015 | science

UCL and Takeda announce a new research partnership

Aims the identification of novel therapeutic targets for neurodegenerative diseases

Read news
Takeda

24-Jan-2011 | research and development

Evotec to Collaborate with Takeda Cambridge for Multi-target Hit Identification

Evotec AG  announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and ...

Read news
Takeda

24-Aug-2010 | research and development

Approval of Additional Indication of NESINA: Combination Therapy with Thiazolidinediones for Type 2 Diabetes in Japan

Takeda Pharmaceutical Company Limited announced that an additional indication for “NESINA®” (generic name: Alogliptin), combination therapy with ...

Read news
Takeda

31-Aug-2009 | research and development

Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin for Treatment of Type 2 Diabetes

Takeda Pharmaceutical Company Limited and Takeda Global Research & Development Center, Inc., a wholly owned United States subsidiary, jointly announced ...

Read news
Takeda

25-Aug-2009 | business & finance

Takeda Reacquires Rights to Diabetes Drug in Canada

Takeda Canada, Inc. announced that it has reacquired the Canadian commercial rights to ACTOS(R) (pioglitazone HCl), an oral treatment for type 2 diabetes, ...

Read news
Takeda

23-Apr-2008 | business & finance

Kinaxo Biotechnologies Enters Agreement with Takeda

Kinaxo Biotechnologies announced that it has entered an agreement with Takeda San Diego, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company ...

Read news
Show more news about Takeda

Here you will find Takeda San Diego, Inc.